Logo Logo
Switch Language to German

Gorog, A., Antiga, E., Caproni, M., Cianchini, G., De, D., Dmochowski, M., Dolinsek, J., Drenovska, K., Feliciani, C., Hervonen, K., Jukic, I. Lakos, Kinyo, A., Koltai, T., Korponay-Szabo, I., Marzano, A. V., Patsatsi, A., Rose, C., Salmi, T., Schmidt, E., Setterfield, J., Shahid, M., Sitaru, C., Uzun, S., Valitutti, F., Vassileva, S., Yayli, S. and Sardy, M. (2021): S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). In: Journal of the European Academy of Dermatology and Venereology, Vol. 35, No. 6: pp. 1251-1277

Full text not available from 'Open Access LMU'.


Introduction Dermatitis herpetiformis (DH) is a chronic, pruritic, gluten-induced skin disorder characterized by subepidermal granular IgA deposition and a variable degree of enteropathy identical to that seen in coeliac disease. So far, there has been no European consensus about the management of DH. Methods The guidelines were created by small subgroups of a guideline committee consisting of 26 specialists from various medical fields and one patients' representative. The members of the committee then discussed the guidelines and voted for the final version at two consensus meetings. The guidelines were developed under the support of the European Academy of Dermatology and Venereology (EADV) and in collaboration with the European Dermatology Forum (EDF). Results The guidelines summarize evidence-based and expert-based recommendations (S2 level) for the management of DH (see Appendix). Conclusion These guidelines will improve the quality of management of DH and support dermatologists in their diagnostic and therapeutic decisions.

Actions (login required)

View Item View Item